The Psoriasis group | The Control group | z或χ2 | P | |
---|---|---|---|---|
Number, n | 90 | 40 | ||
Age (year) | 44(25-53) | 44(31-50) | -0.374 | 0.709 |
Sex (male), n(%) | 67(74) | 26(65) | 1.213 | 0.271 |
Course of disease (month) | 78(12-120) | |||
Poor economic condition, n (%) | 21(23) | 4(10) | 2.369 | 0.124 |
HAMD score | 3(0-9) | 2(0-4) | -2.115 | 0.034 |
PASI score | 31(21-39) | |||
DLQI score | 5(2-9) | |||
AIS score | 2(0-9) | 0(0-1) | -3.407 | 0.001 |
Phenylephrine (pg/ml) | 30.84(29.16-33.29) | 36.77(29.79-41.18) | -2.679 | 0.007 |
Norepinephrine (pg/ml) | 149.28(141.78-161.13) | 154.52(142.51-163.88) | -1.407 | 0.159 |
Dopamine (pg/ml) | 53.73.(49.73-56.67) | 57.08(52.78-63.11) | -2.916 | 0.004 |